Latest Cancer News

Oncotype DX® Predicts Recurrence Risk in Node-negative and Node-positive Breast Cancer Treated with Tamoxifen or Arimidex (03-9-2010)
Among postmenopausal women with early, hormone receptor-positive breast cancer treated with either tamoxifen (Nolvadex®) or Arimidex® (anastrozole), the Oncotype DX test predicts the risk of distant... Continue Reading

Addition of Hormone Therapy to Radiation Improves Survival in Intermediate-risk, Early-stage Prostate Cancer (03-9-2010)
Short-term hormone therapy delivered before and during moderate-dose radiation therapy improves survival and reduces risk of recurrence compared with radiation alone in men with intermediate-risk, early-stage... Continue Reading

Cystoscopy Alone Is the Most Cost-effective Way to Monitor for Recurrence of Bladder Cancer (03-9-2010)
The addition of a urine test to standard cystoscopy screening in order to monitor for bladder cancer recurrence unnecessarily increases the cost of monitoring as well as the risk for a false-positive... Continue Reading

More Cancer News

Locations

Central Indiana Cancer Centers – Carmel
11725 North Illinois Street, Suite 565
Carmel, IN 46032
Phone: 317-819-5320

Central Indiana Cancer Centers – East
6845 Rama Drive
Indianapolis , IN 46219
Phone: 317-964-5200

Central Indiana Cancer Centers – Fishers
10212 Lantern Road
Fishers, IN 46037
Phone: 317-841-5656

Central Indiana Cancer Centers – Hancock
One Memorial Square, Suite 50
Greenfield, IN 46140
Phone: 317-467-7100

Central Indiana Cancer Centers – South
1346 East County Line Road
Indianapolis, IN 46227
Phone: 317-859-5500